Pay in 4 interest-free payments of $6.09 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
GLP-1 for sleep apnea, alcohol use and cancer risk GLP-1s may address conditions well beyond metabolic diseases: Obstructive sleep apnea: Emerging data suggest GLP-1s improve apnea symptoms. Alcohol use disorder: Patients using liraglutide or semaglutide reduced alcohol consumption by nearly two-thirds. Obesity-related cancers: An observational study of 6,000 adults found that GLP-1 receptor agonists halved the risk of obesity-related cancers compared with usual care
Common side effects include: Nausea and Vomiting: The delayed gastric emptying that supports weight loss can lead to discomfort if portions are too large or meals are poorly timed
Injectable Tirzepatide The company describes this as a "GLP-1/GIP Dual Agonist: Enhanced with L-Carnitine" and presents it as a higher-efficacy option in its marketing materials
A total of 6,062 movies across 2 imaging sessions were collected
US$ 25.76
US$ 29.56
US$ 29.54
